GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Research & Development

Medexus Pharmaceuticals (TSX:MDP) Research & Development : C$11.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medexus Pharmaceuticals's Research & Development for the three months ended in Dec. 2023 was C$2.6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$11.5 Mil.

Medexus Pharmaceuticals Research & Development Historical Data

The historical data trend for Medexus Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Research & Development Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 7.15 11.74 14.32 12.36

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.01 3.11 2.59 3.20 2.61

Medexus Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$11.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals  (TSX:MDP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medexus Pharmaceuticals Research & Development Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Research & Development
Comparable Companies
TSX:CWEB XCNQ:HUGE TSXV:DB XCNQ:MMEN XCNQ:CXXI TSXV:ZYUS TSX:AVNT XCNQ:ACRG.A.U XCNQ:GDNS TSXV:LSL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MEDXF:USA P731:Germany
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Website
https://www.medexus.com
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.